Amey Chalke, analyst at Motilal Oswal, said Glenmark Pharmaceuticals gets substantial business from Russia and the company has faced issues in cash inflows of $22-25 million from Venezuela http://goo.gl/pu7ZUe
http://goo.gl/pu7ZUe
Thursday 24 December 2015
Amey Chalke, analyst at Motilal Oswal, said Glenmark Pharmaceuticals gets substantial business from Russia and the company has faced issues in cash inflows of $22-25 million from Venezuela http://goo.gl/pu7ZUe
Amey Chalke, analyst at Motilal Oswal, said Glenmark Pharmaceuticals gets substantial business from Russia and the company has faced issues in cash inflows of $22-25 million from Venezuela http://goo.gl/pu7ZUe
http://goo.gl/pu7ZUe
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment